Search a title or topic

Over 20 million podcasts, powered by 

Player FM logo
Artwork

Content provided by Xtalks. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Xtalks or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://podcastplayer.com/legal.
Player FM - Podcast App
Go offline with the Player FM app!

Why MASH Matters: The Next Steps in Liver Disease Innovation with 89bio’s Rohan Palekar

35:54
 
Share
 

Manage episode 505509288 series 2900042
Content provided by Xtalks. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Xtalks or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://podcastplayer.com/legal.

In this episode of the Xtalks Life Science Podcast, Editor-in-Chief Vera Kovacevic speaks with Rohan Palekar, CEO of 89bio, about one of the fastest-growing public health challenges: metabolic dysfunction-associated steatohepatitis (MASH), also known as fatty liver disease.

MASH is projected to affect more than 27 million Americans by 2030, yet it remains a largely “silent” epidemic.

Palekar discusses what sets MASH apart from other liver diseases, the urgent need for therapies that can rapidly reverse fibrosis in advanced patients and the unique challenges drug developers face in addressing this condition.

The conversation explores the drivers behind the sharp rise in MASH prevalence and what may define the future therapeutic landscape.

Palekar also reflects on his leadership journey at 89bio and shares what’s next for the company as it advances new therapies for MASH and beyond.

Tune in to learn how 89bio is working to transform care for patients living with MASH and why this disease represents one of the most important — yet underrecognized — health challenges of the decade.

For more life science and medical device content, visit the Xtalks Vitals homepage. https://xtalks.com/vitals/
Follow Us on Social Media

Twitter: https://twitter.com/Xtalks
Instagram: https://www.instagram.com/xtalks/
Facebook: https://www.facebook.com/Xtalks.Webinars/
LinkedIn: https://www.linkedin.com/company/xtalks-webconferences
YouTube: https://www.youtube.com/c/XtalksWebinars/featured

  continue reading

222 episodes

Artwork
iconShare
 
Manage episode 505509288 series 2900042
Content provided by Xtalks. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Xtalks or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://podcastplayer.com/legal.

In this episode of the Xtalks Life Science Podcast, Editor-in-Chief Vera Kovacevic speaks with Rohan Palekar, CEO of 89bio, about one of the fastest-growing public health challenges: metabolic dysfunction-associated steatohepatitis (MASH), also known as fatty liver disease.

MASH is projected to affect more than 27 million Americans by 2030, yet it remains a largely “silent” epidemic.

Palekar discusses what sets MASH apart from other liver diseases, the urgent need for therapies that can rapidly reverse fibrosis in advanced patients and the unique challenges drug developers face in addressing this condition.

The conversation explores the drivers behind the sharp rise in MASH prevalence and what may define the future therapeutic landscape.

Palekar also reflects on his leadership journey at 89bio and shares what’s next for the company as it advances new therapies for MASH and beyond.

Tune in to learn how 89bio is working to transform care for patients living with MASH and why this disease represents one of the most important — yet underrecognized — health challenges of the decade.

For more life science and medical device content, visit the Xtalks Vitals homepage. https://xtalks.com/vitals/
Follow Us on Social Media

Twitter: https://twitter.com/Xtalks
Instagram: https://www.instagram.com/xtalks/
Facebook: https://www.facebook.com/Xtalks.Webinars/
LinkedIn: https://www.linkedin.com/company/xtalks-webconferences
YouTube: https://www.youtube.com/c/XtalksWebinars/featured

  continue reading

222 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Copyright 2025 | Privacy Policy | Terms of Service | | Copyright
Listen to this show while you explore
Play